221 related articles for article (PubMed ID: 27477807)
1. Treatment preferences of patients with early rheumatoid arthritis: a discrete-choice experiment.
Hazlewood GS; Bombardier C; Tomlinson G; Thorne C; Bykerk VP; Thompson A; Tin D; Marshall DA
Rheumatology (Oxford); 2016 Nov; 55(11):1959-1968. PubMed ID: 27477807
[TBL] [Abstract][Full Text] [Related]
2. Societal preferences for rheumatoid arthritis treatments: evidence from a discrete choice experiment.
Harrison M; Marra C; Shojania K; Bansback N
Rheumatology (Oxford); 2015 Oct; 54(10):1816-25. PubMed ID: 25989956
[TBL] [Abstract][Full Text] [Related]
3. Patient preferences for biologic agents in rheumatoid arthritis: a discrete-choice experiment.
Augustovski F; Beratarrechea A; Irazola V; Rubinstein F; Tesolin P; Gonzalez J; Lencina V; Scolnik M; Waimann C; Navarta D; Citera G; Soriano ER
Value Health; 2013; 16(2):385-93. PubMed ID: 23538191
[TBL] [Abstract][Full Text] [Related]
4. Benefit-risk trade-offs for treatment decisions in moderate-to-severe rheumatoid arthritis: focus on the patient perspective.
Husni ME; Betts KA; Griffith J; Song Y; Ganguli A
Rheumatol Int; 2017 Sep; 37(9):1423-1434. PubMed ID: 28623526
[TBL] [Abstract][Full Text] [Related]
5. Patients' preferences and economic considerations play an important role in treatment decisions: a discrete choice experiment among rheumatologists.
Hifinger M; Hiligsmann M; Ramiro S; Severens JL; Fautrel B; Watson V; Boonen A
Rheumatology (Oxford); 2017 Jan; 56(1):68-76. PubMed ID: 28028156
[TBL] [Abstract][Full Text] [Related]
6. Economic considerations and patients' preferences affect treatment selection for patients with rheumatoid arthritis: a discrete choice experiment among European rheumatologists.
Hifinger M; Hiligsmann M; Ramiro S; Watson V; Severens JL; Fautrel B; Uhlig T; van Vollenhoven R; Jacques P; Detert J; Canas da Silva J; Scirè CA; Berghea F; Carmona L; Péntek M; Keat A; Boonen A
Ann Rheum Dis; 2017 Jan; 76(1):126-132. PubMed ID: 27190098
[TBL] [Abstract][Full Text] [Related]
7. What do Australian patients with inflammatory arthritis value in treatment? A discrete choice experiment.
Ho KA; Acar M; Puig A; Hutas G; Fifer S
Clin Rheumatol; 2020 Apr; 39(4):1077-1089. PubMed ID: 31858340
[TBL] [Abstract][Full Text] [Related]
8. Patient preferences for treatment of rheumatoid arthritis.
Fraenkel L; Bogardus ST; Concato J; Felson DT; Wittink DR
Ann Rheum Dis; 2004 Nov; 63(11):1372-8. PubMed ID: 15020312
[TBL] [Abstract][Full Text] [Related]
9. Preference phenotypes to facilitate shared decision-making in rheumatoid arthritis.
Fraenkel L; Nowell WB; Michel G; Wiedmeyer C
Ann Rheum Dis; 2018 May; 77(5):678-683. PubMed ID: 29247126
[TBL] [Abstract][Full Text] [Related]
10. What benefit-risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment.
Alten R; Nieto-Gonzalez JC; Jacques P; Montecucco C; Moots R; Radner H; Vonkeman HE; Heidenreich S; Whichello C; Krucien N; Van Beneden K
RMD Open; 2024 Jan; 10(1):. PubMed ID: 38199605
[TBL] [Abstract][Full Text] [Related]
11. Patient preferences for maintenance therapy in Crohn's disease: A discrete-choice experiment.
Hazlewood GS; Pokharel G; Deardon R; Marshall DA; Bombardier C; Tomlinson G; Ma C; Seow CH; Panaccione R; Kaplan GG
PLoS One; 2020; 15(1):e0227635. PubMed ID: 31945089
[TBL] [Abstract][Full Text] [Related]
12. Patients' willingness to trade off between the duration and frequency of rheumatoid arthritis treatments.
Poulos C; Hauber AB; González JM; Turpcu A
Arthritis Care Res (Hoboken); 2014 Jul; 66(7):1008-15. PubMed ID: 24339373
[TBL] [Abstract][Full Text] [Related]
13. Doctors' preferences in de-escalating DMARDs in rheumatoid arthritis: a discrete choice experiment.
Kuijper TM; Folmer R; Stolk EA; Hazes JMW; Luime JJ
Arthritis Res Ther; 2017 Apr; 19(1):78. PubMed ID: 28446212
[TBL] [Abstract][Full Text] [Related]
14. How do patients value features of biological medicine in rheumatoid arthritis? A discrete choice experiment.
Zartab S; Nikfar S; Jamshidi A; Toroski M; Varahrami V; Fatemi B; Kebriaeezadeh A
Expert Rev Pharmacoecon Outcomes Res; 2023; 23(6):701-708. PubMed ID: 37218452
[TBL] [Abstract][Full Text] [Related]
15. Patient preferences on rheumatoid arthritis second-line treatment: a discrete choice experiment of Swedish patients.
Bywall KS; Kihlbom U; Hansson M; Falahee M; Raza K; Baecklund E; Veldwijk J
Arthritis Res Ther; 2020 Dec; 22(1):288. PubMed ID: 33341117
[TBL] [Abstract][Full Text] [Related]
16. Women's Benefits and Harms Trade-Offs in Breast Cancer Screening: Results from a Discrete-Choice Experiment.
Sicsic J; Pelletier-Fleury N; Moumjid N
Value Health; 2018 Jan; 21(1):78-88. PubMed ID: 29304944
[TBL] [Abstract][Full Text] [Related]
17. Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania.
Simons G; Veldwijk J; DiSantostefano RL; Englbrecht M; Radawski C; Bywall KS; Valor Méndez L; Hauber B; Raza K; Falahee M
Rheumatology (Oxford); 2023 Feb; 62(2):596-605. PubMed ID: 36068022
[TBL] [Abstract][Full Text] [Related]
18. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
[TBL] [Abstract][Full Text] [Related]
19. Preferences for treatments to prevent rheumatoid arthritis in Canada and the influence of shared decision-making.
Harrison M; Bansback N; Aguiar M; Koehn C; Shojania K; Finckh A; Hudson M
Clin Rheumatol; 2020 Oct; 39(10):2931-2941. PubMed ID: 32248434
[TBL] [Abstract][Full Text] [Related]
20. Investigating the Heterogeneity in Women's Preferences for Breast Screening: Does the Communication of Risk Matter?
Vass CM; Rigby D; Payne K
Value Health; 2018 Feb; 21(2):219-228. PubMed ID: 29477404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]